GLOBE LIFE INC.·4/A

Apr 28, 3:27 PM ET

Darden James Matthew 4/A

4/A · GLOBE LIFE INC. · Filed Apr 28, 2026

Research Summary

AI-generated summary of this filing

Updated

Globe Life CEO James Darden Exercises Options, Sells 18,318 Shares

What Happened

James Matthew Darden, Co‑Chairman & CEO and Director of Globe Life Inc. (GL), exercised 18,318 options on March 4, 2026 at $100.74 per share (cost ≈ $1,845,355) and sold the 18,318 shares the same day in open‑market transactions for total proceeds ≈ $2,657,995. The filing also shows the related derivative position was canceled (reported as disposed at $0.00). The transactions produced gross proceeds of about $2.66M and a pre‑tax/net‑of‑exercise gain of approximately $812,640.

Key Details

  • Transaction date: March 4, 2026 (Form 4 period); filing amended and submitted April 28, 2026.
  • Exercise (code M): 18,318 shares at $100.74 = $1,845,355 (acquired).
  • Sale (code S): 18,318 shares at an average reported $145.10 = $2,657,995 (disposed). Footnote F2 states sales ranged $145.00–$145.275; F1 notes the reporting person will provide a breakdown of shares sold at each price on request.
  • Related derivative line: 18,318 shares reported as disposed at $0.00 (reflects cancellation of the derivative after exercise).
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Timeliness: This is an amended filing dated Apr 28, 2026 for a Mar 4 transaction (outside the usual 2‑business‑day reporting window).

Context

  • This sequence (exercise followed by same‑day sale) is commonly a cashless exercise—options are exercised and the resulting shares are immediately sold to cover exercise cost/taxes. The filing is factual and does not state motivation.
  • For retail investors: purchases often signal conviction, but same‑day exercises with sales typically reflect option execution and liquidity management rather than a straightforward bullish personal investment.

Insider Transaction Report

Form 4/AAmended
Period: 2026-03-04
Darden James Matthew
DirectorCo-Chairman & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2026-03-04$100.74/sh+18,318$1,845,35576,769.46 total
  • Sale

    Common Stock

    [F1][F2]
    2026-03-04$145.10/sh18,318$2,657,99558,451.46 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2026-03-0418,31826,682 total
    Exercise: $100.74From: 2023-02-26Exp: 2027-02-26Common Stock (18,318 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    4,185.585
Footnotes (2)
  • [F1]Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
  • [F2]Sales at prices ranging from $145.00 per share to $145.275 per share.
Signature
J. Matthew Darden by /s/ Chris T. Moore, Attorney- in-Fact|2026-04-28

Documents

1 file
  • 4
    form4a.xml

    AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES